-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Lexeo Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q3 2024.
- Lexeo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.79M, a 334% increase year-over-year.
- Lexeo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.77M.
- Lexeo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.04M, a 70.9% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)